Vect-Horus;Universite d'Aix-Marseille;Centre National de la Recherche Scientifique
发明人:
Malicet, Cédric,Lecorche, Pascaline,Nowak, Jonathan,David, Marion,Temsamani, Jamal,Khrestchatisky, Michel
申请号：
AU2018211539
公开号：
AU2018211539A1
申请日:
2018.01.30
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present invention relates to a conjugated compound comprising a marker M pharmaceutically acceptable, and a peptide or pseudo-peptide P having at most 30 amino acid residues and able to bind the Low-Density Lipoprotein Receptor (LDLR) and to its use in a method of labelling and/or detecting and/or treating cancerous cells in a subject by administration of the conjugated compound to the subject an analysis of the presence and/or the amount of marker.
